Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Cytokinetics Inc (CYTK)

  • Business News
  • Nov. 14, 2025, 08:06 UTC
  • 20
  • 1 comments

CYTK Investors Have Opportunity to Lead Cytokinetics, Incorporated Securities Fraud Lawsuit with the Schall Law Firm

Market reaction Comment Full text

Jasper Therapeutics Inc. (JSPR)

  • Business News
  • Nov. 14, 2025, 08:04 UTC
  • 20
  • 1 comments

Jasper Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - JSPR

Market reaction Comment Full text

Cytokinetics Inc (CYTK)

  • Business News
  • Nov. 14, 2025, 08:00 UTC
  • 17
  • 1 comments

Cytokinetics, Incorporated Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CYTK

Market reaction Comment Full text

Nanobiotix S.A. (NBTX)

  • Business News
  • Nov. 14, 2025, 07:00 UTC
  • 20
  • 1 comments

Voting Rights and Shares Capital of the Company

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Nov. 14, 2025, 06:13 UTC
  • 17
  • 1 comments

A Man on the Inside Season 2

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Nov. 14, 2025, 06:11 UTC
  • 18
  • 1 comments

How To Turn Off Active Status On Instagram

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Nov. 14, 2025, 06:10 UTC
  • 21
  • 1 comments

High Refresh Rate Monitors: 2026 Tech Advancements and Performance

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Nov. 14, 2025, 05:56 UTC
  • 21
  • 1 comments

How to Log Out of Netflix on TV (Step-by-Step Guide)

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Nov. 14, 2025, 05:54 UTC
  • 21
  • 1 comments

House of the Dragon Season 3: Latest News, Info, and Updates

Market reaction Comment Full text

Verastem Inc (VSTM)

  • Business News
  • Nov. 14, 2025, 05:41 UTC
  • 20
  • 1 comments

Verastem Oncology Announces Pricing of $90 Million Public Offering of Common Stock and Pre-Funded Warrants

Market reaction Comment Full text
  • Previous
  • 629
  • 630
  • 631
  • 632
  • 633
  • Next

Search

News categories

  • Technical Exchange News(10951)
  • Event(2415)
  • SEC News(192768)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(125517)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin